Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
Authors
Keywords
-
Journal
Viruses-Basel
Volume 12, Issue 5, Pages 488
Publisher
MDPI AG
Online
2020-04-28
DOI
10.3390/v12050488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study
- (2020) Luigi Aurisicchio et al. Journal of Translational Medicine
- Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
- (2020) Joan Kha-Tu Ho et al. Viruses-Basel
- Synthetic biology for bioengineering virus-like particle vaccines
- (2019) Hayley K. Charlton Hume et al. BIOTECHNOLOGY AND BIOENGINEERING
- Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
- (2019) Katrin Kramer et al. Journal of Immunology Research
- Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
- (2019) Mona O. Mohsen et al. Journal for ImmunoTherapy of Cancer
- Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine
- (2019) Mona O. Mohsen et al. Frontiers in Immunology
- Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy
- (2019) Nicole M. Maphis et al. npj Vaccines
- Virus‐like particles for vaccination against cancer
- (2019) Mona O. Mohsen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
- (2019) Patrik Andersson et al. Frontiers in Immunology
- Current Perspectives in Cancer Immunotherapy
- (2019) Theodoulakis Christofi et al. Cancers
- VLPs Derived from the CCMV Plant Virus Can Directly Transfect and Deliver Heterologous Genes for Translation into Mammalian Cells
- (2019) María V. Villagrana-Escareño et al. Biomed Research International
- Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter
- (2018) Roberto Ruiu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- Immunogenicity evaluation of MS2 phage-mediated chimeric nanoparticle displaying an immunodominant B cell epitope of foot-and-mouth disease virus
- (2018) Guoqiang Wang et al. PeerJ
- Virus-like particle display of HER2 induces potent anti-cancer responses
- (2018) Arianna Palladini et al. OncoImmunology
- An overview of cancer immunotherapeutic strategies
- (2018) Braira Wahid et al. Immunotherapy
- Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature
- (2018) Hélène Boigard et al. VACCINE
- Reactive oxygen species and cancer paradox: To promote or to suppress?
- (2017) Sehamuddin Galadari et al. FREE RADICAL BIOLOGY AND MEDICINE
- Production of virus-like particles for vaccines
- (2017) J. Fuenmayor et al. New Biotechnology
- Display of single-chain variable fragments on bacteriophage MS2 virus-like particles
- (2017) Christopher A. Lino et al. JOURNAL OF NANOBIOTECHNOLOGY
- A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo
- (2017) Elisabetta Bolli et al. OncoImmunology
- Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer
- (2017) Braeden Donaldson et al. Journal for ImmunoTherapy of Cancer
- Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine
- (2017) Xiajun Hu et al. Scientific Reports
- Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
- (2016) Kimberly J. Briggs et al. CELL
- The immune system and cancer evasion strategies: therapeutic concepts
- (2016) S. Muenst et al. JOURNAL OF INTERNAL MEDICINE
- Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
- (2016) Claudia Cavelti-Weder et al. MOLECULAR THERAPY
- Functional RNAs: combined assembly and packaging in VLPs
- (2016) Po-Yu Fang et al. NUCLEIC ACIDS RESEARCH
- Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
- (2016) Kimia Kardani et al. VACCINE
- A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles
- (2016) Shubing Tang et al. Scientific Reports
- Engineering virus-like particles as vaccine platforms
- (2016) Kathryn M Frietze et al. Current Opinion in Virology
- The application of virus-like particles as vaccines and biological vehicles
- (2015) Dan Yan et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
- (2015) Nikolai Petrovsky DRUG SAFETY
- In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
- (2015) P. H. Lizotte et al. Nature Nanotechnology
- A cholesterol-lowering VLP vaccine that targets PCSK9
- (2015) Erin Crossey et al. VACCINE
- Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2
- (2015) Ebenezer Tumban et al. VACCINE
- Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins
- (2015) Xiao Zhang et al. Human Vaccines & Immunotherapeutics
- Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform
- (2015) Jerri Caldeira et al. PLoS One
- A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein
- (2014) Rosalynn L Ord et al. MALARIA JOURNAL
- Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes
- (2014) Gunther Spohn et al. Molecular Therapy-Methods & Clinical Development
- Reengineering viruses and virus-like particles through chemical functionalization strategies
- (2013) Mark Thomas Smith et al. CURRENT OPINION IN BIOTECHNOLOGY
- An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy
- (2013) Khairunadwa Jemon et al. PLoS One
- Mesothelin Virus-Like Particle Immunization Controls Pancreatic Cancer Growth through CD8+ T Cell Induction and Reduction in the Frequency of CD4+foxp3+ICOS− Regulatory T Cells
- (2013) Sheng Zhang et al. PLoS One
- A universal virus-like particle-based vaccine for human papillomavirus: Longevity of protection and role of endogenous and exogenous adjuvants
- (2013) Ebenezer Tumban et al. VACCINE
- The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
- (2012) Jan Lewerenz et al. ANTIOXIDANTS & REDOX SIGNALING
- Viral and Non-Viral Approaches for Transient Delivery of mRNA and Proteins
- (2012) Juliane W. Schott et al. CURRENT GENE THERAPY
- Differential Approaches for Vaccination from Childhood to Old Age
- (2012) Martina Prelog GERONTOLOGY
- Study designs for the nonclinical safety testing of new vaccine products
- (2012) Roy Forster JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Virus-like particles: innate immune stimulators
- (2011) Ramadevi Raghunandan Expert Review of Vaccines
- Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response
- (2011) Baidong Hou et al. IMMUNITY
- Chimeric Trop2 Virus-like Particles
- (2011) Rafael Cubas et al. JOURNAL OF IMMUNOTHERAPY
- Peptide Epitope Identification by Affinity Selection on Bacteriophage MS2 Virus-Like Particles
- (2011) Bryce Chackerian et al. JOURNAL OF MOLECULAR BIOLOGY
- Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides
- (2011) Jerri C Caldeira et al. JOURNAL OF NANOBIOTECHNOLOGY
- Virus-like particles in vaccine development
- (2010) António Roldão et al. Expert Review of Vaccines
- Repetitive Antigen Stimulation Induces Stepwise Transcriptome Diversification but Preserves a Core Signature of Memory CD8+ T Cell Differentiation
- (2010) Thomas C. Wirth et al. IMMUNITY
- From Vaccines to Memory and Back
- (2010) Federica Sallusto et al. IMMUNITY
- The germinal center reaction
- (2010) Dominique Gatto et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Profile of a Serial Killer: Cellular and Molecular Approaches to Study Individual Cytotoxic T-Cells following Therapeutic Vaccination
- (2010) Emanuela M. Iancu et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Type I IFN enhances follicular B cell contribution to the T cell–independent antibody response
- (2010) Cristina L. Swanson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Virus-Like Particle-Based Anti-Nerve Growth Factor Vaccine Reduces Inflammatory Hyperalgesia: Potential Long-Term Therapy for Chronic Pain
- (2010) T. A. Rohn et al. JOURNAL OF IMMUNOLOGY
- Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402
- (2010) Toshiyuki Baba et al. Journal of Translational Medicine
- First-in-human clinical trials with vaccines—what regulators want
- (2010) Karen B Goetz et al. NATURE BIOTECHNOLOGY
- Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation
- (2010) Shane Crotty et al. NATURE IMMUNOLOGY
- Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
- (2010) Alain C. Tissot et al. PLoS One
- xCT deficiency accelerates chemically induced tumorigenesis
- (2010) A. Nabeyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7
- (2010) Jerri do Carmo Caldeira et al. VACCINE
- Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma
- (2009) Fei-Xiang Ding et al. HEPATOLOGY
- Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes
- (2009) Rafael Cubas et al. JOURNAL OF IMMUNOTHERAPY
- Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells
- (2009) Sheng Zhang et al. MOLECULAR IMMUNOLOGY
- Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases
- (2008) Gary T. Jennings et al. Annual Review of Pharmacology and Toxicology
- The coming of age of virus-like particle vaccines
- (2008) Gary T. Jennings et al. BIOLOGICAL CHEMISTRY
- High expression of TROP2 correlates with poor prognosis in pancreatic cancer
- (2008) D Fong et al. BRITISH JOURNAL OF CANCER
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunogenic Display of Diverse Peptides on Virus-like Particles of RNA Phage MS2
- (2008) David S. Peabody et al. JOURNAL OF MOLECULAR BIOLOGY
- Mesothelin-Induced Pancreatic Cancer Cell Proliferation Involves Alteration of Cyclin E via Activation of Signal Transducer and Activator of Transcription Protein 3
- (2008) U. Bharadwaj et al. MOLECULAR CANCER RESEARCH
- Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer
- (2008) M. Li et al. MOLECULAR CANCER THERAPEUTICS
- Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway
- (2008) R-S Chen et al. ONCOGENE
- Antigen kinetics determines immune reactivity
- (2008) Pål Johansen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now